(NBOS) Neuberger Berman Trust - Ratings and Ratios
Exchange: NYSE ARCA • Country: USA • Currency: USD • Type: Etf • ISIN: US64135A7054 • Equity Hedged
NBOS: Options, Indices, ETFs
The Neuberger Berman ETF Trust (NYSE ARCA: NBOS) employs a distinct investment strategy centered on writing collateralized put options on U.S. indices, with a primary focus on the S&P 500® Index and other indices within the S&P 500® suite. Additionally, the fund writes put options on ETFs. When the fund writes (sells) a put option, the total notional exposure of the options written is generally equal to 100% of the funds total assets. This approach is designed to generate income while maintaining exposure to the underlying indices, leveraging the funds collateral to secure the options written.
The fund operates in the Equity Hedged category, offering a unique risk-adjusted return profile. By writing put options, the fund aims to capitalize on the premiums received from option buyers, effectively monetizing the volatility of the underlying indices. The strategy is collateralized, meaning the fund holds assets to cover potential obligations arising from the options written. This approach is typically employed to generate consistent income while maintaining a defensive posture in volatile markets.
As of the latest data, the fund has approximately $450.48 million in assets under management (AUM), indicating a moderate scale of operations. The average daily trading volume of 141,968 shares suggests reasonable liquidity for investors. The funds current price of $26.21 is slightly below its 20-day and 50-day simple moving averages (SMAs) of $26.60 and $26.36, respectively, but above its 200-day SMA of $25.37. The Average True Range (ATR) of 0.25 reflects relatively low volatility in recent trading activity.
3-Month Forecast Based on the provided data, the fund is expected to maintain a stable price range with minimal volatility. The 200-day SMA of $25.37 suggests support at current levels, while the 20-day and 50-day SMAs indicate potential resistance near $26.60 and $26.36, respectively. With an ATR of 0.25, daily price fluctuations are likely to remain subdued. The funds income-generating strategy, combined with its hedged equity exposure, positions it for steady performance in a low-volatility environment.Additional Sources for NBOS ETF
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
NBOS ETF Overview
Market Cap in USD | 447m |
Category | Equity Hedged |
TER | 0.56% |
IPO / Inception | 2016-09-16 |
NBOS ETF Ratings
Growth Rating | 38.3 |
Fundamental | - |
Dividend Rating | 26.8 |
Rel. Strength | -4.69 |
Analysts | - |
Fair Price Momentum | 22.69 USD |
Fair Price DCF | - |
NBOS Dividends
Dividend Yield 12m | 7.94% |
Yield on Cost 5y | 8.57% |
Annual Growth 5y | -47.57% |
Payout Consistency | 100.0% |
NBOS Growth Ratios
Growth Correlation 3m | -85.9% |
Growth Correlation 12m | 68% |
Growth Correlation 5y | 81.8% |
CAGR 5y | 6.35% |
CAGR/Max DD 5y | 0.50 |
Sharpe Ratio 12m | 1.69 |
Alpha | -2.43 |
Beta | 0.633 |
Volatility | 17.73% |
Current Volume | 20.4k |
Average Volume 20d | 31k |
As of May 01, 2025, the stock is trading at USD 24.97 with a total of 20,352 shares traded.
Over the past week, the price has changed by +1.64%, over one month by -1.73%, over three months by -4.40% and over the past year by +6.63%.
Partly, yes. Based on ValueRay Analyses, Neuberger Berman Trust (NYSE ARCA:NBOS) is currently (May 2025) ok to buy, but has to be watched. It has a Growth Technical Rating of 38.34 and therefor an somewhat technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of NBOS as of May 2025 is 22.69. This means that NBOS is currently overvalued and has a potential downside of -9.13%.
Neuberger Berman Trust has no consensus analysts rating.
According to ValueRays Forecast Model, NBOS Neuberger Berman Trust will be worth about 25.4 in May 2026. The stock is currently trading at 24.97. This means that the stock has a potential upside of +1.84%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 25.4 | 1.8% |